ONFARLA
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99310774
- Mark type
- Stylized text
- Filed
- 30 Jul 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Joel R. Feldman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders.
Owner
- Corcept Therapeutics Incorporated, Redwood City, CA, US
- Corcept Therapeutics Incorporated, Redwood City, CA, US
Prosecution history
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Oct 2025 — NON-FINAL ACTION E-MAILED
- 23 Oct 2025 — NON-FINAL ACTION WRITTEN
- 23 Oct 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 22 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2025 — ASSIGNED TO EXAMINER
- 30 Jul 2025 — APPLICATION FILING RECEIPT MAILED